Modern Medicine’s Makeunder
What goes up must come down. And what goes forward can always come back to serve the many, not the few
Ruth Steer |
Craig Robertson shares the story of Epipole in our cover feature (read more) – and it was a tale we were more than keen to tell. Founded to help bring advanced yet inexpensive imaging technologies to neglected countries, Epipole has centered its business model on ‘doing good’ – but have experienced commercial success along the way.
Clearly, companies need to make money, not only to keep the ‘lights on’, but also to drive research and development, and to iteratively improve upon technologies and treatments. But it seems to me that, with the wonders of the modern world, there exists the potential for disruptive low-cost solutions that can make a huge difference to those who need it most. And that’s precisely what Robertson and his team have focused on; through cunning, perseverance (and not the pursuit of profit), they have adapted high-tech imaging solutions to provide inexpensive and portable fundus imaging devices – and all without compromising quality.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.